These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 30219939)

  • 1. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease.
    Liesinger AM; Graff-Radford NR; Duara R; Carter RE; Hanna Al-Shaikh FS; Koga S; Hinkle KM; DiLello SK; Johnson MF; Aziz A; Ertekin-Taner N; Ross OA; Dickson DW; Murray ME
    Acta Neuropathol; 2018 Dec; 136(6):873-885. PubMed ID: 30219939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
    Kouri N; Frankenhauser I; Peng Z; Labuzan SA; Boon BDC; Moloney CM; Pottier C; Wickland DP; Caetano-Anolles K; Corriveau-Lecavalier N; Tranovich JF; Wood AC; Hinkle KM; Lincoln SJ; Spychalla AJ; Senjem ML; Przybelski SA; Engelberg-Cook E; Schwarz CG; Kwan RS; Lesser ER; Crook JE; Carter RE; Ross OA; Lachner C; Ertekin-Taner N; Ferman TJ; Fields JA; Machulda MM; Ramanan VK; Nguyen AT; Reichard RR; Jones DT; Graff-Radford J; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K; Day GS; Duara R; Graff-Radford NR; Dickson DW; Lowe VJ; Vemuri P; Murray ME
    JAMA Neurol; 2024 Jun; 81(6):619-629. PubMed ID: 38619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
    Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
    JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation.
    Petersen C; Nolan AL; de Paula França Resende E; Miller Z; Ehrenberg AJ; Gorno-Tempini ML; Rosen HJ; Kramer JH; Spina S; Rabinovici GD; Miller BL; Seeley WW; Heinsen H; Grinberg LT
    Acta Neuropathol; 2019 Oct; 138(4):597-612. PubMed ID: 31250152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study.
    Whitwell JL; Dickson DW; Murray ME; Weigand SD; Tosakulwong N; Senjem ML; Knopman DS; Boeve BF; Parisi JE; Petersen RC; Jack CR; Josephs KA
    Lancet Neurol; 2012 Oct; 11(10):868-77. PubMed ID: 22951070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain.
    Moloney CM; Labuzan SA; Crook JE; Siddiqui H; Castanedes-Casey M; Lachner C; Petersen RC; Duara R; Graff-Radford NR; Dickson DW; Mielke MM; Murray ME
    Alzheimers Dement; 2023 Mar; 19(3):1029-1040. PubMed ID: 35920592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes.
    Boon BDC; Labuzan SA; Peng Z; Matchett BJ; Kouri N; Hinkle KM; Lachner C; Ross OA; Ertekin-Taner N; Carter RE; Ferman TJ; Duara R; Dickson DW; Graff-Radford NR; Murray ME
    Neurology; 2023 Oct; 101(14):e1412-e1423. PubMed ID: 37580158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of Apolipoprotein E genotype on regional pathology in Alzheimer's disease.
    Sabbagh MN; Malek-Ahmadi M; Dugger BN; Lee K; Sue LI; Serrano G; Walker DG; Davis K; Jacobson SA; Beach TG
    BMC Neurol; 2013 May; 13():44. PubMed ID: 23663404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
    Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
    Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in the clinical manifestations of Alzheimer disease pathology.
    Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
    Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
    Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
    J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.
    Heyman A; Fillenbaum GG; Gearing M; Mirra SS; Welsh-Bohmer KA; Peterson B; Pieper C
    Neurology; 1999 Jun; 52(9):1839-44. PubMed ID: 10371532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in Alzheimer's disease and common neuropathologies of aging.
    Oveisgharan S; Arvanitakis Z; Yu L; Farfel J; Schneider JA; Bennett DA
    Acta Neuropathol; 2018 Dec; 136(6):887-900. PubMed ID: 30334074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.
    Brenowitz WD; Monsell SE; Schmitt FA; Kukull WA; Nelson PT
    J Alzheimers Dis; 2014; 39(3):691-702. PubMed ID: 24270205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.